Experimental Photodynamic Treatment of Canine Bladder
- 1 February 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 133 (2) , 311-315
- https://doi.org/10.1016/s0022-5347(17)48929-4
Abstract
In urology, important limiting factors in the application of hematoporphyrin derivative and photodynamic therapy appear to be the problems of standardization of dosimetry and the technique of transurethral photoradiation. Experimental photodynamic therapy on canine bladder with normal and altered epithelium was performed using an Arg laser as an energy source. A 630 nm wavelength of light was delivered through a quartz-optical fiber with either a regular flat end for focal illumination or a bulb-type end which produced an isotropic light pattern. It was demonstrated that normal canine bladder was resistant to photodynamic therapy and that the bulb tip produced whole bladder illumination. With a moderate light dose of 18-30 J/cm.2 the effect following whole bladder illumination on the bladder was generalized and superficial. This approach appears to be ideal for treating superficial transitional cell carcinoma of the bladder. Additional work is needed in selecting appropriate energy doses.This publication has 6 references indexed in Scilit:
- Photoradiation Therapy of Bladder TumorsJournal of Urology, 1983
- Temperature rise during photoradiation therapy of malignant tumorsMedical Physics, 1983
- Photoradiation Therapy for Cutaneous and Subcutaneous MalignanciesJournal of Investigative Dermatology, 1981
- Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the BladderJournal of Urology, 1976
- Photodynamic destruction of human bladder carcinomaBritish Journal of Cancer, 1975
- The Use of a Derivative of Hematoporphyrin in Tumor Detection23JNCI Journal of the National Cancer Institute, 1961